The UNC Lineberger Comprehensive Cancer Center requests renewal of its National Cancer Institute (NCI) Center Core Support Grant (CCSG) for Years 20 - 24. Five years ago peer reviewers and the NCI recognized the UNC Lineberger's growth in size and in excellence by increasing the Center's CCSG by almost 50%. In the past five years the UNC Lineberger has continued that same pattern of development: total sponsored funding has doubled (from $20 million to more than $53 million); cancer-related funding has more than doubled (from $16 million to about $43 million); and NCI funding has increased (from $7 million to $16 million). In 1990 the NCI designated the UNC Lineberger a Comprehensive Cancer Center and in 1992 awarded the Center one of the four Specialized Programs of Research Excellence (SPOREs) in Breast Cancer. With a planned doubling in size of its current building and growing institutional support, the UNC Lineberger is poised for continued growth in its research programs, particularly in areas of high national priority: cancer prevention and control, especially in minority populations; molecular epidemiology; clinical/translational research; and molecular therapeutics and gene therapy. Accordingly, the Center seeks significant new support with a CCSG totaling $1.875 million in direct costs. The proposed plan and budget for Years 20-24 will: (1) expand existing support to match the Center's recent growth in size and excellence; (2) commit resources to new and expanded programs and core resources that can capitalize on Center potential in high priority areas; and (3) provide developmental funds to stimulate targeted recruitment and innovation in core resources and pilot project research. The Center is adding two new clinical programs: a Breast Cancer program based on the UNC SPORE; and a Radiation Oncology program that combines basic , clinical, and computer science/imaging research. The Center is expanding or adding new shared resources to serve high priority areas: a new Animal Models core that combines histopathology and analysis of gene expression with expertise in creating transgenic, gene knockout, or human tumor mouse models; a new Cancer Prevention and Control core that provides expertise in the implementation of community-oriented research projects; refashioned existing cores to add support for clinical/translational research, including the Clinical Protocol Office, Tissue Procurement and Analysis, and Flow Cytometry; and an expanded Biostatistics core with increased support for cancer prevention and control, epidemiology and clinical research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-24
Application #
2712527
Study Section
Cancer Center Support Review Committee (CCS)
Program Officer
Shafik, Hasnaa
Project Start
1981-08-01
Project End
1999-11-30
Budget Start
1998-08-05
Budget End
1999-11-30
Support Year
24
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Hu, Jiemiao; Sun, Chuang; Bernatchez, Chantale et al. (2018) T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors. Clin Cancer Res 24:2920-2934
DeKroon, Robert M; Gunawardena, Harsha P; Edwards, Rachel et al. (2018) Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. MBio 9:
Bailey, Rachel M; Armao, Diane; Nagabhushan Kalburgi, Sahana et al. (2018) Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy. Mol Ther Methods Clin Dev 9:160-171
Liu, E; Tong, Y; Dotti, G et al. (2018) Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. Leukemia 32:520-531
Chao, Yvonne L; Pecot, Chad V (2018) Immunotherapy combinations emerging in non-small-cell lung cancer. Immunotherapy 10:627-629
Braithwaite, Dejana; Miglioretti, Diana L; Zhu, Weiwei et al. (2018) Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. JAMA Intern Med 178:494-501
Spencer, Jennifer C; Brewer, Noel T; Trogdon, Justin G et al. (2018) Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients. Am J Public Health 108:946-950
Smith, Collin-Jamal; Allard, Denise E; Wang, Yan et al. (2018) IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration. J Immunol 200:1580-1592
Montgomery, Nathan D; Tomoka, Tamiwe; Krysiak, Robert et al. (2018) Practical Successes in Telepathology Experiences in Africa. Clin Lab Med 38:141-150
Porrello, Alessandro; Leslie, Patrick L; Harrison, Emily B et al. (2018) Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking. Nat Commun 9:1988

Showing the most recent 10 out of 1525 publications